DNMT3AR882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell Frequency
Thomas Köhnke(California Institute for Regenerative Medicine), Ravindra Majeti(California Institute for Regenerative Medicine), Kensuke Kayamori(California Institute for Regenerative Medicine), Jonas L. Fowler(California Institute for Regenerative Medicine), Daiki Karigane(Keio University), Eleanor Hilgart(Johns Hopkins University), Amy C. Fan(Stanford University), Yang Feng(University of Florida), Fabian P. Suchy(Stanford University), Michael A. Koldobskiy(Johns Hopkins University), Andrew P. Feinberg(Johns Hopkins University), Eduardo Martínez‐Montes(Johns Hopkins University), Yusuke Nakauchi(Stanford University), Athreya Rangavajhula(California Institute for Regenerative Medicine), Masashi Miyauchi(California Institute for Regenerative Medicine), Cailin Collins(California Institute for Regenerative Medicine), Hiromitsu Nakauchi(The University of Tokyo), Kyle M. Loh(California Institute for Regenerative Medicine)
Cited by 3
Related Papers
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis
|Nature Biotechnology|2013|1k
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
|Journal of Clinical Oncology|2019|590
Genetic linkage of Beckwith-Wiedemann syndrome to 11p15.
|PubMed|1989|308
Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells.
|Molecular and Cellular Biology|1989|205
Rapid Chromatin Switch in the Direct Reprogramming of Fibroblasts to Neurons
|Cell Reports|2017|146